NRIX Sale Disclosure
Hansen Gwenn · SEC Form 4 · Filed Sep 1, 2026
Sale
Calculated transaction value
$36.98K
Hansen Gwenn Chief Scientific Officer
NRIX
Nurix Therapeutics
NRIX
Transaction date
Sep 1, 2026
Public filing date
Sep 1, 2026
Filing lag
Filed same day
NRIX daily price context
Close on/before transaction
$26.04
Sep 1, 2026
Close before public filing
$25.78
Aug 31, 2026
Return since public filing
-2.64%
Through Sep 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 1,452 shares @ $25.47
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001817160-26-000019
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$39.68K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Nurix Therapeutics, Inc. NRIX Current | Sale | Sep 1, 2026 | $36.98K |
| Nurix Therapeutics, Inc. NRIX | Exercise | Sep 1, 2026 | $2.7K |
| Nurix Therapeutics, Inc. NRIX | Exercise | Sep 1, 2026 | $0 |